Regulatory fervor in the dietary supplements industry seems to wax and wane with the political tides. Right now it's approaching a fever pitch. Here's a look at a couple of areas of particular concern.
I have a friend who's a magician — Professor Phelyx. His repertoire includes a truly jaw-dropping signature trick — a standard-issue restaurant fork that ends up bent, twisted and splayed, with most of that happening while an audience member is holding the fork in her hand.
But even Phelyx can't conjure a magic weight-loss pill.
Conjuring up a weight-loss pill that miraculously (and safely) enables people to shed unwanted pounds without changing their eating habits or exercising more simply isn't possible. But that doesn't stop companies from trying.
A journey of a thousand miles begins with a single step, as any barstool philosopher will tell you. In the case of Sabinsa, the journey to becoming one of the world's largest and most diversified purveyors of herbal ingredients started with a step backward, and another sideways.
Earlier today the Food and Drug Administration announced a decision to approve the AquAdvantage Salmon—a genetically engineered fish that can grow to market size more rapidly than non-GE salmon because it contains genes from a Chinook salmon and anocean pout....More